rs67760762
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001244710.2(GFPT1):c.408+30T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 1,216,722 control chromosomes in the GnomAD database, including 93,521 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 9054 hom., cov: 32)
Exomes 𝑓: 0.39 ( 84467 hom. )
Consequence
GFPT1
NM_001244710.2 intron
NM_001244710.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.553
Genes affected
GFPT1 (HGNC:4241): (glutamine--fructose-6-phosphate transaminase 1) This gene encodes the first and rate-limiting enzyme of the hexosamine pathway and controls the flux of glucose into the hexosamine pathway. The product of this gene catalyzes the formation of glucosamine 6-phosphate. [provided by RefSeq, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-69359238-A-G is Benign according to our data. Variant chr2-69359238-A-G is described in ClinVar as [Benign]. Clinvar id is 258543.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-69359238-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.413 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFPT1 | NM_001244710.2 | c.408+30T>C | intron_variant | ENST00000357308.9 | NP_001231639.1 | |||
GFPT1 | NM_002056.4 | c.408+30T>C | intron_variant | NP_002047.2 | ||||
GFPT1 | XM_017003801.2 | c.483+30T>C | intron_variant | XP_016859290.1 | ||||
GFPT1 | XM_017003802.3 | c.483+30T>C | intron_variant | XP_016859291.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFPT1 | ENST00000357308.9 | c.408+30T>C | intron_variant | 5 | NM_001244710.2 | ENSP00000349860.4 | ||||
GFPT1 | ENST00000361060.5 | c.408+30T>C | intron_variant | 1 | ENSP00000354347.4 | |||||
GFPT1 | ENST00000674507.1 | c.408+30T>C | intron_variant | ENSP00000501332.1 | ||||||
GFPT1 | ENST00000674438.1 | c.192+30T>C | intron_variant | ENSP00000501469.1 |
Frequencies
GnomAD3 genomes AF: 0.311 AC: 47295AN: 151960Hom.: 9042 Cov.: 32
GnomAD3 genomes
AF:
AC:
47295
AN:
151960
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.370 AC: 92875AN: 250888Hom.: 18674 AF XY: 0.375 AC XY: 50851AN XY: 135608
GnomAD3 exomes
AF:
AC:
92875
AN:
250888
Hom.:
AF XY:
AC XY:
50851
AN XY:
135608
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.389 AC: 413765AN: 1064642Hom.: 84467 Cov.: 15 AF XY: 0.389 AC XY: 213123AN XY: 548196
GnomAD4 exome
AF:
AC:
413765
AN:
1064642
Hom.:
Cov.:
15
AF XY:
AC XY:
213123
AN XY:
548196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.311 AC: 47313AN: 152080Hom.: 9054 Cov.: 32 AF XY: 0.311 AC XY: 23121AN XY: 74310
GnomAD4 genome
AF:
AC:
47313
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
23121
AN XY:
74310
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1001
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Congenital myasthenic syndrome 12 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at